EMAIL THIS PAGE TO A FRIEND

SpringerPlus

Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.


PMID 26312209

Abstract

Clinical trials and epidemiological evidence have shown that combined estrogen/progestin hormone replacement therapy, but not estrogen therapy alone, increases breast cancer risk in post-menopausal women. Previously we have shown that natural and synthetic progestins, including the widely used synthetic progestin medroxyprogesterone acetate (MPA), increase production of a potent angiogenic factor, vascular endothelial growth factor (VEGF), in human breast cancer cells, potentially providing an explanation for progestin's mechanism of action. Here, we tested the effects of luteolin (LU), a flavonoid commonly found in fruits and vegetables, on inhibiting progestin-dependent VEGF induction and angiogenesis in human breast cancer cells, inhibiting stem cell-like characteristics, as well as breast cancer cell xenograft tumor growth in vivo and expression of angiogenesis markers. Viability of both T47-D and BT-474 cells was measured using sulforhodamine B assays. Enzyme-linked immunosorbent assays were used to monitor VEGF secretion from breast cancer cells. Progestin-dependent xenograft tumor growth was used to determine LU effects in vivo. CD31 immunohistochemistry was used to determine blood-vessel density in xenograft tumors. CD44 expression, aldehyde dehydrogenase activity, and mammosphere-formation assays were used to monitor stem cell-like characteristics of breast cancer cells. Luteolin treatment reduced breast cancer cell viability, progestin-dependent VEGF secretion from breast cancer cells, and growth of MPA-dependent human breast cancer cell xenograft tumors in nude mice. LU treatment also decreased xenograft tumor VEGF expression and blood-vessel density. Furthermore, LU blocked MPA-induced acquisition of stem cell-like properties by breast cancer cells. Luteolin effectively blocks progestin-dependent human breast cancer tumor growth and the stem cell-like phenotype in human breast cancer cells.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300348
Anti-PGR (Ab-190) antibody produced in rabbit, affinity isolated antibody
HPA004751
Anti-PGR antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV100687
Anti-PGR antibody produced in rabbit, affinity isolated antibody
SAB2101781
Anti-PGR antibody produced in rabbit, affinity isolated antibody
HPA008428
Anti-PGR antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2105280
Anti-PGR antibody produced in rabbit, affinity isolated antibody
HPA017176
Anti-PGR antibody produced in rabbit, Ab3, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
GW22679 Anti-Progesterone Receptor antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB4502184
Anti-Progesterone Receptor antibody produced in rabbit, affinity isolated antibody
SAB4502185
Anti-Progesterone Receptor antibody produced in rabbit, affinity isolated antibody
SAB4502186
Anti-Progesterone Receptor antibody produced in rabbit, affinity isolated antibody
HPA053794
Anti-TMEM37 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
L9283
Luteolin, ≥98% (TLC), powder
C15H10O6
M6013
Medroxyprogesterone
C22H32O3
WH0005241M1
Monoclonal Anti-PGR antibody produced in mouse, clone 3E11, purified immunoglobulin, buffered aqueous solution
SAB1400206
Monoclonal Anti-PGR antibody produced in mouse, clone 5D10, purified immunoglobulin, buffered aqueous solution
SAB1400207
Monoclonal Anti-PGR antibody produced in mouse, clone 4E9, purified immunoglobulin, buffered aqueous solution
SAB1404196
Monoclonal Anti-PGR, (N-terminal) antibody produced in mouse, clone 2C2, purified immunoglobulin, buffered aqueous solution
537543
Propylene glycol monomethyl ether acetate, 99%
C6H12O3